Bronch-UK researchers are involved in a number of poster and spoken presentations at the ERS meeting in Amsterdam in September.

Posters:

Atorvastatin as an anti-inflammatory in bronchiectasis.   Pallavi Bedi, James Chalmers, Adriano Rossi, Adam Hill

Audit investigating self-management of bronchiectasis at University Hospital Llandough, Wales.   Sabena Ali, Jamie Duckers, Dawn Lau

The impact of acute air pollution fluctuations on non-cystic fibrosis bronchiectasis pulmonary exacerbations: A case-crossover analysis. Pieter Goeminne, Pallavi Bedi, Michal Kicinski, Lauren Richardson, Kees De Hoogh, Ben Nemery, Tim Nawrot, Michael Loebinger, Adam Hill, Lieven Dupont

Patients in randomized clinical trials of bronchiectasis are only partially representative of clinical practice: A European cohort study.  James Chalmers, Melissa McDonnell, Pieter Goeminne, John Davidson, Robert Rutherford, Megan Crichton, Thomas Fardon, Adam Hill, Lieven Dupont, Stefano Aliberti, Anthony De-Soyza

Baseline demographic profile of subjects of the phase 3 RESPIRE 1 trial of ciprofloxacin dry powder for inhalation (DPI) in non-cystic fibrosis bronchiectasis (NCFB). Anthony De Soyza, Timothy Aksamit, Elisabeth Operschall, Tiemo-Joerg Bandel, Ulrike Krahn, Margarita Criollo, Robert Wilson

Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients.  Y.K. Hilliam, A. Perry, A.J. Hall, J. Davison, K.E. Walton, J. Fothergill, A. De Soyza, C. Winstanley

Talks:

Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC).  James Chalmers, Eva Polverino, Anthony De Soyza, Felix Ringshausen, Marlene Murris, Wim Boersma, Antoni Torres, Montserrat Vendrell, J. Stuart Elborn, Francesco Blasi, Stefano Aliberti.  On Behalf of the EMBARC Clinical Research Collaboration.

Determinants and assessment of excess cardiovascular risk in bronchiectasis.  Aarash Saleh, Bessie Kwok, Jeremy Brown, John Hurst

Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group.  Stefano Aliberti, Eva Polverino, Anthony De Soyza, Michael R. Loebinger, Rosario Menendez, Felix C. Ringshausen, Montserrat Vendrell, James D. Chalmers

                                         Dr James Chalmers                                                                                                      Prof Stuart Elborn               

                                                   Dr Tony De-Soyza                                                                    Patients talking about bronchiectasis